Showing 1 - 1 results of 1 for search 'Wenqiang Lin', query time: 0.02s
Refine Results
-
1
First-line nivolumab plus ipilimumab for unresectable MPM in China: a cost-effectiveness analysis by Liu Yang, Xiaobing Song, Wanxian Zeng, Zhiwei Zheng, Wenqiang Lin
Published 2023-10-01
Article